Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Respiratory Syncytial Virus News

News
CDC Recommends RSV Vaccination for Older Adults Who Have Not Received It
08/07/2024
Studies are currently investigating how long protection lasts after receiving the respiratory syncytial virus (RSV) vaccine.
Studies are currently investigating how long protection lasts after receiving the respiratory syncytial virus (RSV) vaccine.
Studies are currently...
08/07/2024
Pharmacy Learning Network
News
Officials Will Continue to Assess Guillain-Barré Syndrome Risk After RSV Vaccine
06/12/2024
Jolynn Tumolo
Consistent with prelicensure clinical trials, nearly a year of respiratory syncytial virus (RSV) vaccine use in US older adults showed higher-than-expected rates of Guillain-Barré syndrome after RSV vaccination compared with after COVID-19...
Consistent with prelicensure clinical trials, nearly a year of respiratory syncytial virus (RSV) vaccine use in US older adults showed higher-than-expected rates of Guillain-Barré syndrome after RSV vaccination compared with after COVID-19...
Consistent with prelicensure...
06/12/2024
Pharmacy Learning Network
News
Hospitalized Older Adults With RSV Commonly Experience Severe Acute Cardiac Events, Study Finds
05/30/2024
Lisa Kuhns, PhD
Hospitalized older adults with respiratory syncytial virus (RSV) often have acute cardiac events that are associated with severe clinical outcomes, according to a study published in JAMA Network Open.
Hospitalized older adults with respiratory syncytial virus (RSV) often have acute cardiac events that are associated with severe clinical outcomes, according to a study published in JAMA Network Open.
Hospitalized older adults with...
05/30/2024
Pharmacy Learning Network

Advertisement

News
Pre-RSV Vaccine Era: RSV Severity Matches or Exceeds COVID-19 and Influenza in Hospitalized Patients
05/16/2024
Lisa Kuhns, PhD
Before the vaccine for respiratory syncytial virus (RSV), the virus was as severe as COVID-19 or influenza among unvaccinated patients, but more severe than COVID-19 or influenza among vaccinated patients hospitalized with those diseases,...
Before the vaccine for respiratory syncytial virus (RSV), the virus was as severe as COVID-19 or influenza among unvaccinated patients, but more severe than COVID-19 or influenza among vaccinated patients hospitalized with those diseases,...
Before the vaccine for...
05/16/2024
Pharmacy Learning Network
News
Outcomes Worse in Adults Hospitalized With RSV than Influenza
04/09/2024
Jolynn Tumolo
US adults hospitalized with respiratory syncytial virus (RSV) were more likely to have cardiopulmonary conditions, undergo longer hospital stays, and need mechanical ventilation compared with those hospitalized with influenza, according to a...
US adults hospitalized with respiratory syncytial virus (RSV) were more likely to have cardiopulmonary conditions, undergo longer hospital stays, and need mechanical ventilation compared with those hospitalized with influenza, according to a...
US adults hospitalized with...
04/09/2024
Pharmacy Learning Network
News
Just 1 in 10 Older Americans Vaccinated Against RSV by Fall 2023
04/02/2024
Jolynn Tumolo
Most surveyed Americans older than 60 said they were unlikely to seek out respiratory syncytial virus (RSV) vaccination for the 2023-2024 season, according to a study published online in Health Affairs Scholar.
Most surveyed Americans older than 60 said they were unlikely to seek out respiratory syncytial virus (RSV) vaccination for the 2023-2024 season, according to a study published online in Health Affairs Scholar.
Most surveyed Americans older...
04/02/2024
Pharmacy Learning Network

Advertisement

News
Complex Dynamics of the Respiratory Syncytial Virus (RSV) Surge
01/18/2024

Lisa Kuhns, PhD

Lisa Kuhns, PhD
Nonviral factors may have also contributed to the surge, including changes in population immunity due to altered RSV dynamics resulting from interventions during the COVID-19 pandemic.
Nonviral factors may have also contributed to the surge, including changes in population immunity due to altered RSV dynamics resulting from interventions during the COVID-19 pandemic.
Nonviral factors may have also...
01/18/2024
Pharmacy Learning Network
News
RSV Can Infect Nerve Cells, Triggering Damage
01/15/2024
Jolynn Tumolo
“Until this study, the theory was that the inflammatory response was indirectly activating the nerves,” said study corresponding author Giovanni Piedimonte, MD, FAAP, FCCP, vice president for research and professor of pediatrics,...
“Until this study, the theory was that the inflammatory response was indirectly activating the nerves,” said study corresponding author Giovanni Piedimonte, MD, FAAP, FCCP, vice president for research and professor of pediatrics,...
“Until this study, the theory...
01/15/2024
Pharmacy Learning Network
News
Debate Emerges Over Pfizer's Disclosure of Safety Signal in RSV Vaccine Trial
11/20/2023
Hannah Musick
An investigation by The BMJ has Pfizer facing criticism for failing to inform pregnant women participating in an RSV vaccine trial of the suspension of a similar GSK trial due to a safety concern regarding preterm birth.
An investigation by The BMJ has Pfizer facing criticism for failing to inform pregnant women participating in an RSV vaccine trial of the suspension of a similar GSK trial due to a safety concern regarding preterm birth.
An investigation by The BMJ has...
11/20/2023
Pharmacy Learning Network

Advertisement

News
Balancing Potential Prevention Strategies for Respiratory Syncytial Virus With Continued Emphasis on Supportive Care as Optimal Treatment
11/15/2023

Lisa Kuhns, PhD

Lisa Kuhns, PhD
Specific therapies are lacking for treating respiratory syncytial virus (RSV), and while current prevention strategies offer great potential, supportive care remains the best treatment, according to a study published in Pathogens.
Specific therapies are lacking for treating respiratory syncytial virus (RSV), and while current prevention strategies offer great potential, supportive care remains the best treatment, according to a study published in Pathogens.
Specific therapies are lacking...
11/15/2023
Pharmacy Learning Network

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use